Corporate Profile
Reborna Biosciences, Inc.

Corporate Profile

Profile

Company name Reborna Biosciences, Inc.
Street address 26-1, Muraoka-Higashi 2-chome, Fujisawa, Kanagawa, 251-8555 Japan (Shonan Health Innovation Park)
Phone number +81-466-96-0208
Representative Director Koji Fuji
Establishment Feb. 20, 2018
Capital 100 million yen (as of Dec. 31, 2025)
Business description Research and development of small molecule drugs targeting RNA for genetically rare diseases.
Number of employees 14 (as of Aug. 1, 2026)
Board Members
Representative Director
Koji Fuji
Director
Yukimi Oda
Outside Director
Yutaro Kasai
Outside Director
Shigeki Nakata
Outside Director
Nobuyuki Takagi
Outside Audit & Supervisory Board Member (Full-time)
Shigeru Momose
Outside Audit & Supervisory Board Member (Part-time)
Yuji Anzai
Outside Audit & Supervisory Board Member (Part-time)
Shunsuke Watanabe
Advisor Yasushi Shingai

History

2018.2 Establishment of Reborna Biosciences, Inc.
2018.4 Start of business
2018.5 Seed Round funding through third-party allotment
2019.6 PCT international patent application for PROPHYLACTIC OR THERAPEUTIC AGENT FOR SPINAL MUSCULAR ATROPHY (PCT/JP2019/025732) PCT international patent application for PROPHYLACTIC OR THERAPEUTIC AGENT FOR LYSOSOMAL ACID LIPASE DEFICIENCY (PCT/JP2019/048232)
2019.12 Completes equity financing through third-party allotment of new shares
2021.4 Entering into a research collaboration, option and license agreement with Biogen MA, Inc.
2021.9 Completes equity financing through third-party allotment of new shares
2023.4 Completes equity financing through third-party allotment of new shares
2024.9 Enters into a Research Collaboration with Kissei Pharmaceutical
2025.3 Enters into a Research and Licensing Agreement with Ono Pharmaceutical
2025.5 Completes equity financing through third-party allotment of new shares
2025.10 Named a Finalist in Three Categories at the Citeline Japan Awards 2025
2025.10 Achieves First Milestone in Research Collaboration with Kissei
2025.10 Joins JLABS Singapore
2026.5 Completes additional equity financing through third-party allotment of new shares
2026.8 Achieves Second Milestone in Research Collaboration with Kissei
2026.8 Achieves First Milestone in Research Collaboration with Ono

Access

26-1, Muraoka-Higashi 2-chome, Fujisawa, Kanagawa, 251-8555 Japan (Shonan iPark)

<By Train and Bus>

From JR Ofuna Station:
Bus: Take the Enoden bus bound for Fujisawa Station Kitaguti (East Exit bus terminal, bus stop No.1) to Shonan iPark stop (Approx. 15 mins)
Taxi: After exiting through the South Exit, take taxi from West-side taxi terminal (Approx. 10 mins)
From Fujisawa Station:
Bus: Take the Enoden bus bound for Ofuna Station Higashiguchi (North Exit bus terminal, bus stop No.9) to Shonan iPark stop (Approx. 15 mins)
Taxi: After exiting through the North Exit, take Taxi from taxi terminal (Approx. 10 mins)

<By Car>

From Tokyo
About 11 km from the Kamiyabe Interchange on the Yokohama Bypass via Route 1 Harajuku
From Odawara
About 6 km from the Fujisawa Interchange on the Shin-Shonan Bypass via Fujisawa-Bashi